Today AIT THERAPEUTICS INC (OTCMKTS:AITB) Reported Increase in Shorted Shares

April 17, 2018 - By reb123z

The stock of AIT THERAPEUTICS INC (OTCMKTS:AITB) registered an increase of 600% in short interest. AITB’s total short interest was 1,400 shares in April as published by FINRA. Its up 600% from 200 shares, reported previously. The short interest to AIT THERAPEUTICS INC’s float is 0.05%.

The stock decreased 6.67% or $0.2 during the last trading session, reaching $2.8. About 300 shares traded. AIT Therapeutics, Inc. (OTCMKTS:AITB) has 0.00% since April 17, 2017 and is . It has underperformed by 11.55% the S&P500.

AIT Therapeutics, Inc., a biopharmaceutical company, engages in developing a single proprietary formulation of 160 parts per million of nitric oxide and delivery systems to treat respiratory infections. The company has market cap of $23.51 million. The companyÂ’s pipeline includes therapies against respiratory infections in acute and chronic diseases, such as severe bronchiolitis , cystic fibrosis related lung infections (CF), and non-tuberculosis mycobacterial (NTM) infections. It currently has negative earnings. It has completed two Phase II trials to treat RSV and CF related lung infections, as well as conducted a treatment for patients with CF who suffer from NTM infections.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: